Related Experiment Videos

[Secondary prevention in the elderly or very elderly patient: indications, limitations and...perspectives]

P Jourdain1

  • 1Service de cardiologie, CH René-Dubos, 6, avenue de l'lle-de-France, 95300 Pontoise. Patrick.jourdain@ch-pontoise.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|January 24, 2007
PubMed

Insights

Secondary prevention of cardiovascular diseases is crucial for the elderly. Addressing risk factors like dyslipidemia, smoking, and hypertension, alongside patient education and a multidisciplinary approach, improves outcomes in older adults.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Public Health

Context:

  • Cardiovascular diseases remain the leading cause of mortality in developed nations, especially among the elderly.
  • Despite advances, secondary prevention strategies are often underutilized in older populations.
  • The elderly population presents unique challenges and opportunities for cardiovascular disease management.

Purpose:

  • To highlight the importance of secondary prevention of cardiovascular diseases in the elderly population.
  • To emphasize the benefits of managing major risk factors in older adults.
  • To advocate for a comprehensive and multidisciplinary approach to elderly cardiovascular care.

Summary:

  • The elderly can significantly benefit from the correction of major cardiovascular risk factors, including dyslipidemia, smoking, and hypertension.
  • Physical activity and patient education are vital components for managing cardiovascular health in autonomous elderly individuals.
  • Systematic assessment of treatment tolerance and adherence, coupled with a multidisciplinary team (cardiologist, GP, geriatrician, nursing staff), is essential for optimal secondary prevention.

Impact:

  • Improved cardiovascular outcomes and reduced mortality in the elderly population.
  • Enhanced quality of life for older adults through effective disease management.
  • A shift towards more inclusive and comprehensive secondary prevention strategies for geriatric patients.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...